Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Siemens Healthineers Ag (SHL.D.DX)

Siemens Healthineers Ag (SHL.D.DX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Siemens Healthineers Ag Siemensstr. 3 Forchheim BY 91301 DEU

P: 913-184-3385

Description:

Siemens Healthineers is engaged in therapeutic imaging, radiotherapy, laboratory, and point-of-care diagnostics. The imaging segment (55% of sales in fiscal 2023) includes magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound. The Varian segment (16% of sales) offers radiotherapy and other oncology solutions. The portfolio of the diagnostics segment (21%) includes in vitro diagnostics products offered to providers and point-of-care diagnostics. The advanced therapies segment (9%) products are designed to support image-guided minimally invasive treatments in cardiology, interventional radiology, and surgery. North America represents 41% of total sales, Europe, Middle East, and Africa 32%, and Asia-Pacific including China the remainder.

Key Statistics

Overview:

Market Capitalization, $K 57,584,048
Shares Outstanding, K 1,118,571
Annual Sales, $ 21,680 M
Annual Net Income, $ 1,509 M
Last Quarter Sales, $ 5,423 M
Last Quarter Net Income, $ 469,000 K
% of Institutional Shareholders 13.56%

Growth:

1-Year Return 9.89%
3-Year Return -14.87%
5-Year Return 0.00%
5-Year Revenue Growth 10.05%
5-Year Earnings Growth 1.24%

Per-Share Information:

Most Recent Earnings 0.42 on 07/31/24
Next Earnings Date N/A
Earnings Per Share ttm 1.66
EPS Growth vs. Prev Qtr 10.53%
EPS Growth vs. Prev Year 16.90%
Annual Dividend Rate, $ 0.95
Annual Dividend Yield 1.98%
Most Recent Dividend 0.950 on 04/19/24
Next Ex-Dividends Date 04/19/24
Dividend Payable Date 04/23/24
Dividend Payout Ratio 57.23%

SHL.D.DX Ratios

Ratio
Price/Earnings ttm 28.90
Price/Earnings forward 17.70
Price/Earnings to Growth 1.08
Return-on-Equity % 10.52%
Return-on-Assets % 4.04%
Profit Margin % 6.96%
Debt/Equity 0.02
Price/Sales 2.43
Price/Cash Flow 24.56
Price/Book 2.94
Book Value/Share 16.30
Interest Coverage 7.51
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar